Biogen

BIIB · Health Care · Market cap $30.7B

Q1 FY26 Jan 1 – Mar 31, 2026 reported Jul 29, 2026

Revenue$2.48B +2% year over year

Gross profit$1.82B

Operating profit$0.46B

Net profit$0.32B 13% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.48	100%	+2%
Cost of revenue	−0.66	27%
Gross profit	1.82	73% margin	−1pp
SG&A	−0.61	25%	+1pp
Other	−0.75	30%	+0pp
Operating profit	0.46	19% margin	+0pp
Tax	−0.06
Interest & other costs	−0.08
Net profit	0.32	13%	+3pp

Quarter by quarter

So far we hold one set of results. Another one arrives with the next filing.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Jan 1 – Mar 31, 2026	Jul 29, 2026	$2.5B	+2%	19%	$0.32B	13%